Security key
15117B202
Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (CLDX)
CUSIP: 15117B202
Q1 2021 13F Holders as of 31 Mar 2021
- Type / Class
- Equity / Common Stock, par value $0.001
- Shares outstanding
- 80,000,000
- Total 13F shares
- 34,503,199
- Share change
- -2,290,040
- Total reported value
- $709,497,850
- Put/Call ratio
- 66%
- Price per share
- $20.60
- Number of holders
- 109
- Value change
- -$40,255,166
- Number of buys
- 55
- Number of sells
- 65
Report period
Q1 2021
Institutions
109
Top holders
10
CLDX full security history
Newer quarter: Q2 2021
Previous quarter: Q4 2020
Celldex Therapeutics, Inc. SEC filings
Celldex Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 15117B202
Recent filing periods:
Top shareholders of CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
|
Company |
4.3%
|
3,422,855
|
$59,968,000 | — | 31 Dec 2020 | |
| Redmile Group, LLC |
13F
|
Company |
3.4%
|
2,711,616
|
$47,508,000 | — | 31 Dec 2020 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
3.1%
|
2,500,000
|
$43,800,000 | — | 31 Dec 2020 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
1,837,108
|
$32,186,000 | — | 31 Dec 2020 | |
| STATE STREET CORP |
13F
|
Company |
2.3%
|
1,810,260
|
$31,716,000 | — | 31 Dec 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.2%
|
1,767,915
|
$30,973,000 | — | 31 Dec 2020 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
2%
|
1,627,500
|
$28,514,000 | — | 31 Dec 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.7%
|
1,396,516
|
$24,467,000 | — | 31 Dec 2020 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.7%
|
1,364,990
|
$23,915,000 | — | 31 Dec 2020 | |
| Vivo Capital, LLC |
13F
|
Company |
1.6%
|
1,291,875
|
$22,634,000 | — | 31 Dec 2020 | |
| Marshall Wace North America L.P. |
13F
|
Company |
1.6%
|
1,281,624
|
$22,454,000 | — | 31 Dec 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.3%
|
1,048,827
|
$18,375,000 | — | 31 Dec 2020 | |
| Octagon Capital Advisors LP |
13F
|
Company |
1.3%
|
1,041,398
|
$18,245,000 | — | 31 Dec 2020 | |
| Boxer Capital, LLC |
13F
|
Company |
1.2%
|
1,000,000
|
$17,520,000 | — | 31 Dec 2020 | |
| Polar Capital Holdings Plc |
13F
|
Company |
1.2%
|
1,000,000
|
$17,520,000 | — | 31 Dec 2020 | |
| Opaleye Management Inc. |
13F
|
Company |
1.2%
|
992,000
|
$17,380,000 | — | 31 Dec 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.1%
|
861,381
|
$15,092,000 | — | 31 Dec 2020 | |
| Venrock Adviser, LLC |
13F
|
Company |
1%
|
800,000
|
$14,016,000 | — | 31 Dec 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.8%
|
642,303
|
$11,253,000 | — | 31 Dec 2020 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.75%
|
597,198
|
$10,463,000 | — | 31 Dec 2020 | |
| Cresset Asset Management, LLC |
13F
|
Company |
0.57%
|
457,666
|
$8,018,000 | — | 31 Dec 2020 | |
| TSP Capital Management Group, LLC |
13F
|
Company |
0.5%
|
403,229
|
$7,065,000 | — | 31 Dec 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.5%
|
401,556
|
$7,035,000 | — | 31 Dec 2020 | |
| Artal Group S.A. |
13F
|
Company |
0.5%
|
400,000
|
$7,008,000 | — | 31 Dec 2020 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.49%
|
393,215
|
$6,889,000 | — | 31 Dec 2020 | |
| Commodore Capital LP |
13F
|
Company |
0.45%
|
356,431
|
$6,245,000 | — | 31 Dec 2020 | |
| S.c.a. Candriam |
13F
|
Individual |
0.43%
|
344,139
|
$6,030,000 | — | 31 Dec 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.39%
|
311,737
|
$5,462,000 | — | 31 Dec 2020 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.38%
|
307,915
|
$5,395,000 | — | 31 Dec 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.37%
|
299,054
|
$5,239,000 | — | 31 Dec 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.37%
|
293,068
|
$5,135,000 | — | 31 Dec 2020 | |
| Altium Capital Management LLC |
13F
|
Company |
0.3%
|
239,520
|
$4,196,000 | — | 31 Dec 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.26%
|
205,922
|
$3,608,000 | — | 31 Dec 2020 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.25%
|
196,792
|
$3,448,000 | — | 31 Dec 2020 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.22%
|
179,670
|
$3,148,000 | — | 31 Dec 2020 | |
| Verition Fund Management LLC |
13F
|
Company |
0.22%
|
175,539
|
$3,075,000 | — | 31 Dec 2020 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.21%
|
171,318
|
$3,001,000 | — | 31 Dec 2020 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.21%
|
170,591
|
$2,989,000 | — | 31 Dec 2020 | |
| DSAM Partners (London) Ltd |
13F
|
Company |
0.21%
|
170,000
|
$2,978,000 | — | 31 Dec 2020 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.14%
|
114,764
|
$2,011,000 | — | 31 Dec 2020 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.13%
|
100,919
|
$1,768,000 | — | 31 Dec 2020 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.13%
|
100,259
|
$1,757,000 | — | 31 Dec 2020 | |
| MOORE CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.12%
|
95,000
|
$1,664,000 | — | 31 Dec 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.12%
|
94,989
|
$1,664,000 | — | 31 Dec 2020 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.12%
|
94,200
|
$1,650,000 | — | 31 Dec 2020 | |
| Swiss National Bank |
13F
|
Company |
0.11%
|
88,500
|
$1,551,000 | — | 31 Dec 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.11%
|
87,335
|
$1,530,000 | — | 31 Dec 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.1%
|
82,232
|
$1,441,000 | — | 31 Dec 2020 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
80,282
|
$1,407,000 | — | 31 Dec 2020 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.09%
|
75,000
|
$1,314,000 | — | 31 Dec 2020 |
Institutional Holders of Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (CLDX) as of Q1 2021
As of 31 Mar 2021,
Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (CLDX) was held by
109 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,503,199 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, Redmile Group, LLC, EVENTIDE ASSET MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, VANGUARD GROUP INC, Vivo Capital, LLC, VR Adviser, LLC, and ACUTA CAPITAL PARTNERS, LLC.
This page lists
109
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
120
Q1 2021 holders
109
Holder diff
-11
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.